0.730
-0.01 (-1.35%)
| Previous Close | 0.740 |
| Open | 0.740 |
| Volume | 3,306,000 |
| Avg. Volume (3M) | 8,068,586 |
| Market Cap | 7,016,082,944 |
| Price / Earnings (Forward) | 24.21 |
| Price / Sales | 1.31 |
| Price / Book | 1.88 |
| 52 Weeks Range | |
| Earnings Date | 18 Mar 2025 |
| Profit Margin | -2.29% |
| Operating Margin (TTM) | -2.60% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | 5.20% |
| Quarterly Earnings Growth (YOY) | -97.30% |
| Total Debt/Equity (MRQ) | 173.70% |
| Current Ratio (MRQ) | 1.28 |
| Operating Cash Flow (TTM) | 353.53 M |
| Levered Free Cash Flow (TTM) | 87.52 M |
| Return on Assets (TTM) | 0.44% |
| Return on Equity (TTM) | -3.29% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (HK) | Mixed | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | CKLIFE SCIENCES | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 1.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -4.0 |
| Average | -0.63 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| CKLIFE SCIENCES | 7 B | - | - | 1.88 |
| CSTONE PHARMA-B | 14 B | - | - | 27.87 |
| VIVA BIOTECH | 4 B | - | 28.57 | 0.940 |
| ANTENGENE-B | 3 B | - | - | 2.84 |
| SINOMAB BIO-B | 2 B | - | - | 4.23 |
| IMMUNOTECH-B | 2 B | - | - | 20.15 |
|
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related and Health. The company derives maximum revenue from the health segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 74.98% |
| % Held by Institutions | 0.31% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |